G. Grimsley

Sequence differences between HLA-B and TNF distinguish different MHC ancestral haplotypes.

F. Christiansen, M. Degli-Esposti, L. Abraham, 1992, Tissue antigens.

Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.

Gavin Giovannoni, Finn Sellebjerg, Geoffrey Keir, 2005, Archives of neurology.

Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussion

M. Trojano, M. Verbeek, R. Liblau, 2003, Clinical chemistry and laboratory medicine.

Immunological status may predict clinical outcome in BCG treated melanoma.

M. Byrne, P. Zilko, R. Dawkins, 1980, Australian and New Zealand journal of medicine.

Correction of human immunodeficiency virus-associated depression of delayed-type hypersensitivity (DTH) after zidovudine therapy: DTH, CD4+ T-cell numbers, and epidermal Langerhans cell density are independent variables.

M. French, P. Cameron, R. Dawkins, 1990, Clinical immunology and immunopathology.

ANALYSIS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX MICROSATELLITE CL1 IN DIFFERENT HUMAN HAPLOTYPES

L. Abraham, C. Leelayuwat, D. Ulgiati, 1996, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

A region centromeric of the major histocompatibility complex class I region is as highly polymorphic as HLA-B. Implications for recombination.

F. Christiansen, L. Abraham, C. Leelayuwat, 1993, Human immunology.

POLYMORPHISM IN THE HUMAN B144 GENE IN DIFFERENT MHC HAPLOTYPES

M. Degli-Esposti, L. Abraham, R. Dawkins, 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

MHC supratypes as markers of null and defective C4 alleles in a Thai/Chinese population: relevance to disease susceptibility.

P. Kay, R. Dawkins, G. Grimsley, 1987, Disease markers.

Increased binding of D-penicillamine to monocytes in rheumatoid arthritis.

R. Dawkins, G. Grimsley, H. Watanabe, 1986, Clinical Immunology and Immunopathology.

Complement Allotyping Explains MHC Associations in Multiple Sclerosis

I. Mackay, T. Cobain, W. Zhang, 1988, Annals of the New York Academy of Sciences.